2018
DOI: 10.1038/s41443-018-0027-5
|View full text |Cite
|
Sign up to set email alerts
|

Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum

Abstract: Intralesional injection of collagenase clostridium histolyticum (CCH) improves Peyronie’s disease (PD) symptoms; however, patient perspectives regarding PD and CCH treatment have not been fully elucidated. This cross-sectional qualitative study included heterosexual men with PD who received ≥1 injection of study medication and had ≥1 posttreatment Peyronie’s Disease Questionnaire (PDQ) assessment during a prior phase 2b clinical trial. These patients were “responders” if they reported (as part of the Global As… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…Particular counselling points should include that treatments generally may not restore the penis to the premorbid dimensions. 28 , 29 The patient should be informed regarding the pathophysiology of PD in general, as well as the extent of his condition in his specific case.…”
Section: Patient Expectationsmentioning
confidence: 99%
“…Particular counselling points should include that treatments generally may not restore the penis to the premorbid dimensions. 28 , 29 The patient should be informed regarding the pathophysiology of PD in general, as well as the extent of his condition in his specific case.…”
Section: Patient Expectationsmentioning
confidence: 99%